市場調査レポート

商品コード

1626520

インジェクションペン市場：製品、用途、エンドユーザー、ペン付属品、用量、地域別、2024年～2031年

Injection Pen Market By Product, Application, End-Users, Pen Accessories, Dosage, & Region for 2024-2031

出版日: 2024年09月01日
発行: Verified Market Research
ページ情報: 英文 202 Pages
納期: 2～3営業日

価格

PDF (Single User License)

USD 3,950 580,610円

1名のみが、レポートにアクセスする事ができるライセンスです。レポートPDFのダウンロード、印刷は可能です。

PDF & Excel (5 User License)

USD 4,850 712,901円

5名までが、レポートにアクセスする事ができるライセンスです。レポートPDF・関連するExcelシートのダウンロード、印刷は可能です。

PDF & Excel (Enterprise User License)

USD 7,550 1,109,774円

人数制限なく、レポートにアクセスできるライセンスです。PDF形式のレポートと関連するExcel出力シートの両方をダウンロード、印刷する事が可能です。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.99円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

インジェクションペン市場の評価、2024年～2031年

インジェクションペン市場は、糖尿病、関節リウマチ、多発性硬化症などの慢性疾患の有病率の増加により大きく拡大しています。これらの病気では、従来の注射器では困難な、定期的で正確な量の投薬が頻繁に必要となります。インジェクションペンは、このプロセスをかなり簡単にします。インジェクションペンは、患者が最小限の不快感と労力で薬を自己投与できるよう、使いやすさを追求しています。ペンはあらかじめ薬剤が充填されており、投与量の設定を変更できるため、投与が簡単で、投与ミスの可能性も低くなります。市場は2024年に収益19億米ドルを超え、2031年までに評価額約25億8,000万米ドルに達すると予想されています。

技術の進歩は、インジェクションペンをより魅力的なものにしています。開発メーカーは、モバイルアプリに接続して患者にリマインダーを提供したり、薬の使用状況を追跡したりできるスマートペンを開発しています。これらの機能は、慢性疾患を効果的に管理するために重要な治療レジメンのアドヒアランス向上に役立ちます。さらに、在宅ヘルスケアへの傾向の高まりと低侵襲治療への嗜好の高まりが、インジェクションペンの採用を後押ししており、2024年から2031年までのCAGRは3.90%で市場は成長します。

インジェクションペン市場定義/概要

インジェクションペンは、注射針を介して正確な量の薬剤を投与するために使用される医療機器です。巨大なペンに似ており、患者にとって薬物注射の手順をより簡単で便利にすることを目的としています。インジェクションペンは、糖尿病用のインスリン、成長ホルモン、関節リウマチなどの自己免疫疾患の治療などによく使われています。

インジェクションペンの使用は、患者のコンプライアンスを高めると同時に、従来の注射器による注射に伴う恐怖感や不快感を減少させ、治療レジメンを一変させました。糖尿病患者にとって、これらのペンは血糖値を管理する簡単な方法を提供し、より自立したライフスタイルを可能にします。投与量の正確な分配は、健康を維持し問題を回避するために重要な薬剤消費の一貫性に寄与します。さらに、ヘルスケア担当者は、投与プロセスを合理化し、ミスの可能性を低減するペンの簡便性から恩恵を受ける。

インジェクションペンは、ヘルスケアにおいてますます重要になると思われます。注目すべき動向の一つは、使いやすさと自動化の開発が進んでいることです。将来のインジェクションペンは、投与に必要なステップ数を減らし、より幅広い患者が利用できるよう、さらにシンプルな機構を持つようになるかもしれないです。さらに、材料や技術の進歩により、精度と信頼性が向上し、一定の投与量が得られ、注射時の不快感が軽減されると予測されています。

技術進歩の増加はインジェクションペン市場を牽引するか？

インスリン・ペンは、バイアルや注射器のような従来のインスリン投与方法に比べて様々な利点を提供します。患者にとってより簡単で便利なことを目的としています。バイアルから注入しなければならない注射器とは異なり、インスリン・ペンはインスリン・カートリッジがあらかじめ充填されています。このため、特に1日に数回インスリンを必要とする患者にとっては使いやすいです。かさばらず、目立たず、持ち運びが容易であるため、様々な社会的状況において糖尿病管理がより容易になります。インスリンペンの大きな利点の一つは、その使いやすさです。多くの現代的なバージョンは、ほとんど指導を必要としないユーザーフレンドリーであることを意図しています。

自動注射器やボーラスポンプベースのシステムのような注射デバイスの開発は、このような献身を示しています。これらのデバイスは、インスリンを含む医薬品を送達する代替方法を提供することを意図しており、患者のコンプライアンスを向上させながら、安全かつ効果的に医薬品を調剤する能力が評価されています。

インスリンペン、自動注射器、ボーラスポンプベースのシステムのような注射デバイスの出現は、ヘルスケア技術の大きな進歩を意味します。これらの改良は、患者が慢性疾患をより簡単かつ快適に管理できるようにするだけでなく、治療レジメンのアドヒアランス向上にも役立っています。技術の進歩に伴い、世界中の患者のさまざまな要求を満たすため、将来はますます複雑で個別化されたソリューションが期待されます。

代替ドラッグデリバリーはインジェクションペン市場の妨げになるか？

薬物送達の代替形態は、インジェクションペンビジネスに影響を与えるかもしれないが、これは多くの状況に依存しています。代替技術には、経口錠剤、パッチ、吸入器、そして埋め込みデバイスやマイクロニードルなどの最新技術が含まれます。これらの方法にはそれぞれ、利便性、痛みの軽減、薬物放出の延長といった明確な利点があり、注射が困難または不便だと感じている患者にアピールできる可能性があります。例えば経口薬は、その簡便さと非侵襲性から人気があります。多くの人が、インジェクションペンを使うよりも錠剤を摂取する方を選ぶ。この配布方法は、消化器官を経由して分解されずに吸収される医薬品に特に有用です。同様に、経皮パッチは皮膚から薬剤を持続的に放出することができるため、安定した血中濃度を確保し、薬剤の副作用をなくすことができます。

薬物送達の代替形態は、それぞれに利点のある実行可能な解決策を提供するが、インジェクションペンは、その実証された有効性、簡便性、および継続的な技術開発により、依然として人気があります。正確な薬剤、患者の嗜好、病状のタイプは、インジェクションペンを使用するか他の技術を使用するかを決定するために頻繁に使用されます。ヘルスケアが進化するにつれ、インジェクションペン業界は順応し、革新し、患者が利用できる様々な薬物送達方法の中でその地位を確保していくと思われます。

インジェクションペンの世界市場概要
インジェクションペンの世界推定・予測、2021-2030年
世界のインジェクションペンの生態マッピング
競合分析：ファネルダイアグラム
世界のインジェクションペンの絶対的収益機会
インジェクションペンの世界市場の魅力分析、地域別
インジェクションペンの世界市場の魅力分析：製品別
インジェクションペンの世界市場魅力度分析：用途別
インジェクションペンの世界市場魅力度分析：用量別
インジェクションペンの世界市場の魅力分析：エンドユーザー別
インジェクションペンの世界市場の魅力分析：ペン付属品別
インジェクションペンの世界市場別地域分析
インジェクションペンの世界市場：製品別
インジェクションペンの世界市場：用途別
インジェクションペンの世界市場：用量別
インジェクションペンの世界市場：エンドユーザー別
インジェクションペンの世界市場：ペン付属品別
インジェクションペンの世界市場：地域別
今後の市場機会

第4章市場展望

インジェクションペンの世界市場の変遷
インジェクションペン市場の展望
市場促進要因
- 慢性疾患の増加
- 高齢人口の増加
市場抑制要因
- インジェクションペンの高コスト
- 針刺し傷害と誤用
市場動向
- 技術の進歩
- 薬剤の自己投与の人気上昇
市場機会
- 生分解性ペン素材の活用
- 新興市場への進出
ポーターのファイブフォース分析
- 新規参入業者の脅威
- 代替品の脅威
- 供給企業の交渉力
- 買い手の交渉力
- 競争企業間の敵対関係
マクロ経済分析
バリューチェーン分析
価格分析
インジェクションペン用アクセサリーケースの分析
世界の肥満の展望
GLP-1RAの注射器への採用と糖尿病患者および肥満への影響
成長ホルモン欠乏症とその市場動向
インジェクションペンのトップリスト

第5章製品別市場

概要
インジェクションペンの世界市場：製品別、ベーシスポイントシェア（BPS）分析
使い捨て
再使用可能

第6章用量別市場

概要
インジェクションペンの世界市場：用量別、ベーシスポイントシェア（BPS）分析
固定式
バリアブル

第7章用途別市場

概要
インジェクションペンの世界市場：用途別、ベーシスポイントシェア（BPS）分析
糖尿病
アナフィラキシー
骨粗鬆症
成長ホルモン欠乏症
関節炎
その他

第8章エンドユーザー別市場

概要
インジェクションペンの世界市場：エンドユーザー別、ベーシスポイントシェア（BPS）分析
病院・診断センター
在宅ケア

第9章ペン付属品別市場

概要
ペン先
針カバーまたはシールド
キャリーケース
ペングリップまたはホルダー

第10章地域別市場

概要
北米
- 北米市場スナップショット
- 米国
- カナダ
- メキシコ
欧州
- 欧州市場スナップショット
- ドイツ
- 英国
- フランス
- イタリア
- スペイン
- その他欧州
アジア太平洋
- アジア太平洋市場スナップショット
- 中国
- 日本
- インド
- その他アジア太平洋地域
ラテンアメリカ
- ラテンアメリカ市場スナップショット
- ブラジル
- アルゼンチン
- その他ラテンアメリカ
中東・アフリカ
- 中東・アフリカ市場スナップショット
- アラブ首長国連邦
- サウジアラビア
- 南アフリカ
- その他中東とアフリカ

第11章競合情勢

概要
主な発展
企業の市場ランキング分析
地域別フットプリント
ACE MATRIX
- アクティブ
- カッティング・エッジ
- エマージング
- イノベーター

第12章世界のインジェクションペン市場、企業プロファイル

ELI LILLY AND COMPANY
SANOFI SA
NOVO NORDISK A/S
MERCK KGAA
TEVA PHARMACEUTICALS INDUSTRIES LTD.
OWEN MUMFORD
HASELMEIER GMBH
GERRESHEIMER AG
BIOCON LIMITED
BD (BECKTON DISCKINSON CO)
ASTRAZENECA
SHL MEDICAL
NOVARTIS AG
SOLTEAM INCORPORATION CO., LTD.
YPSOMED AG
ROCHE HOLDING AG
NORDIC PHARMA
PHILLIPS-MEDISIZE CORPORATION (A MOLEX COMPANY)
MEDTRONIC

第13章世界のインジェクションペン付属品市場、企業プロファイル

DIABETES EXPRESS
DIABETICWAREHOUSE
4ALLFAMILY

図表

LIST OF TABLES

TABLE 1 PROJECTED REAL GDP GROWTH (ANNUAL PERCENTAGE CHANGE) OF KEY COUNTRIES
TABLE 2 GLOBAL INJECTION PEN MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 3 GLOBAL INJECTION PEN MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 4 GLOBAL INJECTION PEN MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 5 GLOBAL INJECTION PEN MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 6 GLOBAL INJECTION PEN MARKET, BY PEN ACCESSORIES, 2021-2030 (USD MILLION)
TABLE 7 GLOBAL INJECTION PEN MARKET, BY GEOGRAPHY, 2021-2030 (USD MILLION)
TABLE 8 NORTH AMERICA INJECTION PEN MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 9 NORTH AMERICA INJECTION PEN MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 10 NORTH AMERICA INJECTION PEN MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 11 NORTH AMERICA INJECTION PEN MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 12 NORTH AMERICA INJECTION PEN MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 13 NORTH AMERICA INJECTION PEN MARKET, BY PEN ACCESSORIES, 2021-2030 (USD MILLION)
TABLE 14 U.S. INJECTION PEN MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 15 U.S. INJECTION PEN MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 16 U.S. INJECTION PEN MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 17 U.S. INJECTION PEN MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 18 CANADA INJECTION PEN MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 19 CANADA INJECTION PEN MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 20 CANADA INJECTION PEN MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 21 CANADA INJECTION PEN MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 22 MEXICO INJECTION PEN MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 23 MEXICO INJECTION PEN MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 24 MEXICO INJECTION PEN MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 25 MEXICO INJECTION PEN MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 26 EUROPE INJECTION PEN MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 27 EUROPE INJECTION PEN MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 28 EUROPE INJECTION PEN MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 29 EUROPE INJECTION PEN MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 30 EUROPE INJECTION PEN MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 31 EUROPE INJECTION PEN MARKET, BY PEN ACCESSORIES, 2021-2030 (USD MILLION)
TABLE 32 GERMANY INJECTION PEN MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 33 GERMANY INJECTION PEN MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 34 GERMANY INJECTION PEN MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 35 GERMANY INJECTION PEN MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 36 U.K. INJECTION PEN MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 37 U.K. INJECTION PEN MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 38 U.K. INJECTION PEN MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 39 U.K. INJECTION PEN MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 40 FRANCE INJECTION PEN MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 41 FRANCE INJECTION PEN MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 42 FRANCE INJECTION PEN MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 43 FRANCE INJECTION PEN MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 44 ITALY INJECTION PEN MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 45 ITALY INJECTION PEN MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 46 ITALY INJECTION PEN MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 47 ITALY INJECTION PEN MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 48 SPAIN INJECTION PEN MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 49 SPAIN INJECTION PEN MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 50 SPAIN INJECTION PEN MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 51 SPAIN INJECTION PEN MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 52 REST OF EUROPE INJECTION PEN MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 53 REST OF EUROPE INJECTION PEN MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 54 REST OF EUROPE INJECTION PEN MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 55 REST OF EUROPE INJECTION PEN MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 56 ASIA PACIFIC INJECTION PEN MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 57 ASIA PACIFIC INJECTION PEN MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 58 ASIA PACIFIC INJECTION PEN MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 59 ASIA PACIFIC INJECTION PEN MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 60 ASIA PACIFIC INJECTION PEN MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 61 ASIA PACIFIC INJECTION PEN MARKET, BY PEN ACCESSORIES, 2021-2030 (USD MILLION)
TABLE 62 CHINA INJECTION PEN MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 63 CHINA INJECTION PEN MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 64 CHINA INJECTION PEN MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 65 CHINA INJECTION PEN MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 66 JAPAN INJECTION PEN MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 67 JAPAN INJECTION PEN MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 68 JAPAN INJECTION PEN MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 69 JAPAN INJECTION PEN MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 70 INDIA INJECTION PEN MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 71 INDIA INJECTION PEN MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 72 INDIA INJECTION PEN MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 73 INDIA INJECTION PEN MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 74 REST OF ASIA PACIFIC INJECTION PEN MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 75 REST OF ASIA PACIFIC INJECTION PEN MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 76 REST OF ASIA PACIFIC INJECTION PEN MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 77 REST OF ASIA PACIFIC INJECTION PEN MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 78 LATIN AMERICA INJECTION PEN MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 79 LATIN AMERICA INJECTION PEN MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 80 LATIN AMERICA INJECTION PEN MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 81 LATIN AMERICA INJECTION PEN MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 82 LATIN AMERICA INJECTION PEN MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 83 LATIN AMERICA INJECTION PEN MARKET, BY PEN ACCESSORIES, 2021-2030 (USD MILLION)
TABLE 84 BRAZIL INJECTION PEN MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 85 BRAZIL INJECTION PEN MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 86 BRAZIL INJECTION PEN MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 87 BRAZIL INJECTION PEN MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 88 ARGENTINA INJECTION PEN MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 89 ARGENTINA INJECTION PEN MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 90 ARGENTINA INJECTION PEN MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 91 ARGENTINA INJECTION PEN MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 92 REST OF LATIN AMERICA INJECTION PEN MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 93 REST OF LATIN AMERICA INJECTION PEN MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 94 REST OF LATIN AMERICA INJECTION PEN MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 95 REST OF LATIN AMERICA INJECTION PEN MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 96 MIDDLE EAST AND AFRICA INJECTION PEN MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 97 MIDDLE EAST AND AFRICA INJECTION PEN MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 98 MIDDLE EAST AND AFRICA INJECTION PEN MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 99 MIDDLE EAST AND AFRICA INJECTION PEN MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 100 MIDDLE EAST AND AFRICA INJECTION PEN MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 101 MIDDLE EAST AND AFRICA INJECTION PEN MARKET, BY PEN ACCESSORIES, 2021-2030 (USD MILLION)
TABLE 102 UAE INJECTION PEN MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 103 UAE INJECTION PEN MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 104 UAE INJECTION PEN MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 105 UAE INJECTION PEN MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 106 SAUDI ARABIA INJECTION PEN MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 107 SAUDI ARABIA INJECTION PEN MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 108 SAUDI ARABIA INJECTION PEN MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 109 SAUDI ARABIA INJECTION PEN MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 110 SOUTH AFRICA INJECTION PEN MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 111 SOUTH AFRICA INJECTION PEN MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 112 SOUTH AFRICA INJECTION PEN MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 113 SOUTH AFRICA INJECTION PEN MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 114 REST OF MIDDLE EAST AND AFRICA INJECTION PEN MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 115 REST OF MIDDLE EAST AND AFRICA INJECTION PEN MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 116 REST OF MIDDLE EAST AND AFRICA INJECTION PEN MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 117 REST OF MIDDLE EAST AND AFRICA INJECTION PEN MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 118 COMPANY MARKET RANKING ANALYSIS
TABLE 119 COMPANY REGIONAL FOOTPRINT
TABLE 120 ELI LILLY: PRODUCT BENCHMARKING
TABLE 121 ELI LILLY: KEY DEVELOPMENTS
TABLE 122 ELI LILLY: WINNING IMPERATIVES
TABLE 123 SANOFI SA: PRODUCT BENCHMARKING
TABLE 124 SANOFI SA: KEY DEVELOPMENTS
TABLE 125 SANOFI SA: WINNING IMPERATIVES
TABLE 126 NOVO NORDISK A/S: PRODUCT BENCHMARKING
TABLE 127 NOVO NORDISK A/S: KEY DEVELOPMENTS
TABLE 128 NOVO NORDISK A/S: WINNING IMPERATIVES
TABLE 129 MERCK KGAA: PRODUCT BENCHMARKING
TABLE 130 MERCK KGAA: KEY DEVELOPMENTS
TABLE 131 MERCK KGAA: WINNING IMPERATIVES
TABLE 132 TEVA PHARMACEUTICALS: PRODUCT BENCHMARKING
TABLE 133 TEVA PHARMACEUTICALS: KEY DEVELOPMENTS
TABLE 134 TEVA PHARMACEUTICALS INDUSTRIES LTD.: WINNING IMPERATIVES
TABLE 135 OWEN MUMFORD: PRODUCT BENCHMARKING
TABLE 136 OWEN MUMFORD: KEY DEVELOPMENTS
TABLE 137 OWEN MUMFORD: WINNING IMPERATIVES
TABLE 138 HASELMEIER GMBH: PRODUCT BENCHMARKING
TABLE 139 HASELMEIER GMBH: KEY DEVELOPMENTS
TABLE 140 HASELMEIER GMBH: WINNING IMPERATIVES
TABLE 141 GERRESHEIMER AG: PRODUCT BENCHMARKING
TABLE 142 GERRESHEIMER AG: WINNING IMPERATIVES
TABLE 143 BIOCON LIMITED: PRODUCT BENCHMARKING
TABLE 144 BIOCON LIMITED: WINNING IMPERATIVES
TABLE 145 BD: PRODUCT BENCHMARKING
TABLE 146 BD: KEY DEVELOPMENTS
TABLE 147 BD (BECKTON DISCKINSON CO): WINNING IMPERATIVES
TABLE 148 ASTRAZENECA: PRODUCT BENCHMARKING
TABLE 149 ASTRAZENECA: WINNING IMPERATIVES
TABLE 150 SHL MEDICAL: PRODUCT BENCHMARKING
TABLE 151 SHL MEDICAL: KEY DEVELOPMENTS
TABLE 152 SHL MEDICAL: WINNING IMPERATIVES
TABLE 153 NOVARTIS AG: PRODUCT BENCHMARKING
TABLE 154 NOVARTIS AG: KEY DEVELOPMENTS
TABLE 155 NOVARTIS AG: WINNING IMPERATIVES
TABLE 156 SOLTEAM INCORPORATION CO., LTD.: PRODUCT BENCHMARKING
TABLE 157 SOLTEAM INCORPORATION CO., LTD.: KEY DEVELOPMENTS
TABLE 158 SOLTEAM INCORPORATION CO., LTD.: WINNING IMPERATIVES
TABLE 159 YPSOMED AG: PRODUCT BENCHMARKING
TABLE 160 YPSOMED AG: KEY DEVELOPMENTS
TABLE 161 YPSOMED AG: WINNING IMPERATIVES
TABLE 162 ROCHE HOLDING AG: PRODUCT BENCHMARKING
TABLE 163 ROCHE HOLDING AG: KEY DEVELOPMENTS
TABLE 164 ROCHE HOLDING AG: WINNING IMPERATIVES
TABLE 165 NORDIC PHARMA: PRODUCT BENCHMARKING
TABLE 166 NORDIC PHARMA: KEY DEVELOPMENTS
TABLE 167 NORDIC PHARMA: WINNING IMPERATIVES
TABLE 168 PHILLIPS-MEDISIZE CORPORATION: PRODUCT BENCHMARKING
TABLE 169 PHILLIPS-MEDISIZE CORPORATION: KEY DEVELOPMENTS
TABLE 170 PHILLIPS-MEDISIZE CORPORATION: WINNING IMPERATIVES
TABLE 171 MEDTRONIC: PRODUCT BENCHMARKING
TABLE 172 MEDTRONIC: KEY DEVELOPMENTS
TABLE 173 MEDTRONIC: WINNING IMPERATIVES
TABLE 174 DIABETICWAREHOUSE: PRODUCT BENCHMARKING
TABLE 175 4ALLFAMILY: PRODUCT BENCHMARKING

LIST OF FIGURES

FIGURE 1 GLOBAL INJECTION PEN MARKET SEGMENTATION
FIGURE 2 RESEARCH TIMELINES
FIGURE 3 DATA TRIANGULATION
FIGURE 4 MARKET RESEARCH FLOW
FIGURE 5 DATA SOURCES
FIGURE 6 EXECUTIVE SUMMARY
FIGURE 7 GLOBAL INJECTION PEN ESTIMATES AND FORECAST (USD MILLION), 2021-2030
FIGURE 8 COMPETITIVE ANALYSIS: FUNNEL DIAGRAM
FIGURE 9 GLOBAL INJECTION PEN ABSOLUTE MARKET OPPORTUNITY
FIGURE 10 GLOBAL INJECTION PEN MARKET ATTRACTIVENESS ANALYSIS, BY REGION
FIGURE 11 GLOBAL INJECTION PEN MARKET ATTRACTIVENESS ANALYSIS, BY PRODUCT
FIGURE 12 GLOBAL INJECTION PEN MARKET ATTRACTIVENESS ANALYSIS, BY APPLICATION
FIGURE 13 GLOBAL INJECTION PEN MARKET ATTRACTIVENESS ANALYSIS, BY DOSAGE
FIGURE 14 GLOBAL INJECTION PEN MARKET ATTRACTIVENESS ANALYSIS, BY END-USERS
FIGURE 15 GLOBAL INJECTION PEN MARKET ATTRACTIVENESS ANALYSIS, BY PEN ACCESSORIES
FIGURE 16 GLOBAL INJECTION PEN MARKET GEOGRAPHICAL ANALYSIS, 2024-30
FIGURE 17 GLOBAL INJECTION PEN MARKET, BY PRODUCT (USD MILLION)
FIGURE 18 GLOBAL INJECTION PEN MARKET, BY APPLICATION (USD MILLION)
FIGURE 19 GLOBAL INJECTION PEN MARKET, BY DOSAGE (USD MILLION)
FIGURE 20 GLOBAL INJECTION PEN MARKET, BY END-USERS (USD MILLION)
FIGURE 21 GLOBAL INJECTION PEN MARKET, BY PEN ACCESSORIES (USD MILLION)
FIGURE 22 GLOBAL INJECTION PEN MARKET, BY GEOGRAPHY (USD MILLION)
FIGURE 23 FUTURE MARKET OPPORTUNITIES
FIGURE 24 INJECTION PEN MARKET OUTLOOK
FIGURE 25 MARKET DRIVERS_IMPACT ANALYSIS
FIGURE 26 RESTRAINTS_IMPACT ANALYSIS
FIGURE 27 KEY TRENDS
FIGURE 28 PORTER'S FIVE FORCES ANALYSIS
FIGURE 29 GLOBAL INJECTION PEN MARKET, BY PRODUCT
FIGURE 30 GLOBAL INJECTION PEN MARKET BASIS POINT SHARE (BPS) ANALYSIS, BY PRODUCT
FIGURE 31 GLOBAL INJECTION PEN MARKET, BY DOSAGE
FIGURE 32 GLOBAL INJECTION PEN MARKET BASIS POINT SHARE (BPS) ANALYSIS, BY DOSAGE
FIGURE 33 GLOBAL INJECTION PEN MARKET, BY APPLICATION
FIGURE 34 GLOBAL INJECTION PEN MARKET BASIS POINT SHARE (BPS) ANALYSIS, BY APPLICATION
FIGURE 35 GLOBAL INJECTION PEN MARKET, BY END USERS
FIGURE 36 GLOBAL INJECTION PEN MARKET BASIS POINT SHARE (BPS) ANALYSIS, BY END USERS
FIGURE 37 GLOBAL INJECTION PEN MARKET, BY GEOGRAPHY, 2021-2030 (USD MILLION)
FIGURE 38 U.S. MARKET SNAPSHOT
FIGURE 39 CANADA MARKET SNAPSHOT
FIGURE 40 MEXICO MARKET SNAPSHOT
FIGURE 41 GERMANY MARKET SNAPSHOT
FIGURE 42 U.K. MARKET SNAPSHOT
FIGURE 43 FRANCE MARKET SNAPSHOT
FIGURE 44 ITALY MARKET SNAPSHOT
FIGURE 45 SPAIN MARKET SNAPSHOT
FIGURE 46 REST OF EUROPE MARKET SNAPSHOT
FIGURE 47 CHINA MARKET SNAPSHOT
FIGURE 48 JAPAN MARKET SNAPSHOT
FIGURE 49 INDIA MARKET SNAPSHOT
FIGURE 50 REST OF ASIA PACIFIC MARKET SNAPSHOT
FIGURE 51 BRAZIL MARKET SNAPSHOT
FIGURE 52 ARGENTINA MARKET SNAPSHOT
FIGURE 53 REST OF LATIN AMERICA MARKET SNAPSHOT
FIGURE 54 UAE MARKET SNAPSHOT
FIGURE 55 SAUDI ARABIA MARKET SNAPSHOT
FIGURE 56 SOUTH AFRICA MARKET SNAPSHOT
FIGURE 57 REST OF MIDDLE EAST AND AFRICA MARKET SNAPSHOT
FIGURE 58 KEY STRATEGIC DEVELOPMENTS
FIGURE 59 ACE MATRIX
FIGURE 60 ELI LILLY: COMPANY INSIGHT
FIGURE 61 SANOFI SA: COMPANY INSIGHT
FIGURE 62 NOVO NORDISK A/S: COMPANY INSIGHT
FIGURE 63 MERCK KGAA: COMPANY INSIGHT
FIGURE 64 TEVA PHARMACEUTICALS: COMPANY INSIGHT
FIGURE 65 0WEN MUMFORD: COMPANY INSIGHT
FIGURE 66 HASELMEIER GMBH: COMPANY INSIGHT
FIGURE 67 GERRESHEIMER AG: COMPANY INSIGHT
FIGURE 68 BIOCON LIMITED: COMPANY INSIGHT
FIGURE 69 BD: COMPANY INSIGHT
FIGURE 70 ASTRAZENECA: COMPANY INSIGHT
FIGURE 71 SHL MEDICAL: COMPANY INSIGHT
FIGURE 72 NOVARTIS AG: COMPANY INSIGHT
FIGURE 73 SOLTEAM INCORPORATION CO., LTD..: COMPANY INSIGHT
FIGURE 74 YPSOMED AG: COMPANY INSIGHT
FIGURE 75 ROCHE HOLDING AG: COMPANY INSIGHT
FIGURE 76 NORDIC PHARMA: COMPANY INSIGHT
FIGURE 77 PHILLIPS-MEDISIZE CORPORATION: COMPANY INSIGHT
FIGURE 78 MEDTRONIC: COMPANY INSIGHT
FIGURE 79 DIABETES EXPRESS.: COMPANY INSIGHT
FIGURE 80 DIABETES EXPRESS: PRODUCT BENCHMARKING
FIGURE 81 DIABETICWAREHOUSE: COMPANY INSIGHT
FIGURE 82 4ALLFAMILY: COMPANY INSIGHT

Product Code: 26272

Injection Pen Market Valuation - 2024-2031

The injection pen market is expanding significantly due to the increasing prevalence of chronic conditions such as diabetes, rheumatoid arthritis, and multiple sclerosis. These illnesses frequently necessitate regular, exact amounts of medication which can be challenging to administer with conventional syringes. Injection pens make the process considerably easier. They are intended to be user-friendly allowing patients to self-administer medication with minimal discomfort and effort. The pens come pre-filled with medication and feature changeable dose settings making them easy and lowering the chance of dosing errors by enabling the market to surpass a revenue of USD 1.90 Billion valued in 2024 and reach a valuation of around USD 2.58 Billion by 2031.

Advancements in technology are making injection pens even more appealing. Manufacturers are developing smart pens that can connect to mobile apps providing patients with reminders and tracking their medication usage. These features help improve adherence to treatment regimens which is crucial for managing chronic diseases effectively. Additionally, the growing trend towards home healthcare and the increasing preference for minimally invasive treatments are boosting the adoption of injection pens by enabling the market to grow at a CAGR of 3.90% from 2024 to 2031.

Injection Pen Market: Definition/ Overview

Injection pen is a medical gadget used to provide precise amounts of medication via a needle. It resembles a huge pen and is intended to make the procedure of injecting drugs simpler and more convenient for patients. Injection pens are frequently used to provide medications such as insulin for diabetes, growth hormones, and some treatments for autoimmune disorders such as rheumatoid arthritis.

The use of injectable pens has transformed treatment regimens by increasing patient compliance while decreasing the fear and discomfort associated with traditional syringe injections. For diabetic patients, these pens provide a simple way to manage blood sugar levels enabling a more independent lifestyle. Precision in dose distribution contributes to drug consumption consistency which is critical for preserving health and avoiding issues. Furthermore, healthcare personnel benefit from the pens simplicity which streamlines the administration process and reduces the possibility of errors.

Injection pens are likely to become increasingly important in healthcare. One notable trend is their ongoing development in usability and automation. Future injectable pens may have even simpler mechanisms lowering the number of steps necessary for administration and making them available to a broader spectrum of patients. Furthermore, advances in materials and technology are projected to improve their precision and dependability providing constant dosage distribution and reducing discomfort during injection procedures.

Will the Increasing Technological Advancements Drive the Injection Pen Market?

Insulin pens offer various advantages over traditional methods of insulin delivery such as vials and syringes. They are intended to be easier and more convenient for patients. Unlike syringes which must be drawn from a vial and then injected, insulin pens are pre-filled with insulin cartridges. This makes them easier to use particularly for patients who require insulin several times per day. Users find them more rewarding because they are less bulky, inconspicuous, and portable making diabetes management easier in a variety of social situations. One major advantage of insulin pens is their ease of usage. Many contemporary versions are meant to be user-friendly requiring little instruction.

The development of injection devices such as autoinjectors and bolus pump-based systems demonstrates this dedication. These devices are intended to provide alternate methods of delivering pharmaceuticals including insulin, and are evaluated on their capacity to dispense drugs safely and effectively while increasing patient compliance.

The emergence of injection devices like as insulin pens, autoinjectors, and bolus pump-based systems represents a huge step forward in healthcare technology. These improvements not only make it easier and more comfortable for patients to manage chronic illnesses but they also help to enhance treatment regimen adherence. As technology advances, the future promises increasingly more complex and individualized solutions to satisfy the different requirements of patients around the world.

Will Alternative Modes of Drug Delivery Hamper the Injection Pen Market?

Alternative forms of medication delivery may have an impact on the injectable pen business but this relies on a number of circumstances. Alternative techniques include oral pills, patches, inhalers, and more recent technology such as implanted devices or microneedles. Each of these methods provides distinct benefits such as convenience, reduced pain, or extended medication release which may appeal to patients who find injections difficult or inconvenient. Oral drugs, for example, are popular due to their simplicity and non-invasiveness. Many people choose to ingest pills rather than use injectable pens. This method of distribution is especially useful for pharmaceuticals that can be absorbed via the digestive system without degradation. Similarly, transdermal patches allow continuous medication release through the skin, ensuring stable blood levels and eliminating

Alternative forms of medication delivery offer viable solutions with their own set of benefits but injectable pens remain popular because to their proven effectiveness, ease, and continual technical developments. The precise drug, patient preferences, and type of the medical condition are frequently used to determine whether to use injectable pens or other techniques. As healthcare evolves, the injectable pen industry is likely to adapt and innovate ensuring its place among the variety of medication delivery methods available to patients.

Category-Wise Acumens

How Convenience and Ease of Use Drive the Product Segment?

Disposable injection pens is projected to hold major share in the market. This domination stems mostly from the convenience and ease of usage provided by disposable pens. Patients prefer them since they do not require maintenance, cleaning, or the trouble of changing cartridges. These pens are simply thrown after use which is especially useful for people who may struggle to keep a reusable pen in good condition or who want a simple, one-time-use option. This simplicity and user-friendliness increase their popularity among patients resulting in increased adoption rates.

Disposable injectable pens are popular in the healthcare business because they minimize the danger of contamination and infection. Because each pen is only used once, there is less risk of poor cleaning or reuse which can lead to hygiene problems. This makes disposable pens a safer option particularly for frequently injected drugs such as insulin for diabetes. Furthermore, the pharmaceutical industry's emphasis on patient safety and adherence has resulted in the creation of more complex disposable pens including dose memory, automatic needle retraction, and ergonomic designs. These advancements improve the user experience making disposable pens the preferable option. The combination of convenience, safety, and constant innovation has secured the leading position of disposable injection pens in the market.

How do Increasing Awareness and Diagnosis of Diabetes Drive the Application Segment?

The diabetic category dominates the injectable pen market. This dominance stems primarily from the high prevalence of diabetes globally and the need for regular insulin therapy among diabetic individuals. Insulin pens provide diabetics a convenient, accurate, and user-friendly way to manage their condition. Unlike traditional syringes, insulin pens are simple to use, portable, and engineered to provide exact insulin dosages which are critical for keeping blood sugar levels within a specific range. Diabetes therapy necessitates frequently daily injections, therefore demand for insulin pens stays constantly high contributing to the segment's market domination.

As diabetes knowledge and diagnosis have increased so has the number of patients who require insulin therapy. This has fueled innovation and advancements in injectable pen technology making them more accessible and effective for patients. Companies are constantly creating pens with advanced features including digital displays, memory functions, and dose adjusting mechanisms to improve user experience and adherence to therapy. These improvements together with the chronic nature of diabetes and insulin's critical role in its care ensure that the diabetes application category remains the largest and most influential in the injection pen market.

Gain Access into Injection Pen Market Report Methodology

Country/Region-wise Acumens

How Advancement's in Drug Delivery Technology Drive the Market in North America?

North America is expected to hold major share in the market for injectable pens owing to the rising prevalence of chronic diseases and higher healthcare expenditures in the region. Several important reasons are driving the injection pen market including the rising prevalence of chronic diseases and the growing need for user-friendly medication delivery systems.

According to the International Diabetes Federation, the number of individuals with diabetes is anticipated to increase from 537 million in 2021 to 783 million by 2045. This tendency is especially noteworthy in regions like North America where diabetes is common. For example, the US Centers for Disease Control and Prevention (CDC) estimated that approximately 34.2 million people in the United States had diabetes in 2020.

According to the Centers for Disease Control and Prevention, around 34.2 million individuals in the United States have diabetes in 2020 with another 88 million having pre-diabetes. The growing awareness of new drug delivery devices, the widespread availability of injection pens and cartridges, and the emphasis on patient-centered treatment have all contributed to the rise of the North American injection pen industry.

How Growing Awareness about Advanced Medication Delivery Devices Drive the Market in Asia Pacific Region?

Asia Pacific is expected to be the fastest-growing region in the injection pen market owing to the rising incidence of chronic diseases. Also, the rising healthcare spending is upsurging awareness of improved medicine delivery systems, thereby enhancing the sales of injection pen. The rising prevalence of chronic diseases such as cancer, cardiovascular disease, and autoimmune disorders among the Asian Pacific population owing to poor eating habits, physical inactivity, and increasing alcohol consumption is expected to drive demand for injection pens in the region. Furthermore, pharmaceutical makers increasing investments in the research of new pharmaceuticals as well as the increased emphasis on patient-centered care are helping to drive growth in the Asia Pacific injection pen market.

Technological developments in injection pen design such as the incorporation of smart features and increased dosing precision have also contributed significantly to market expansion. These innovations have improved patient adherence and safety making injectable pens more desirable to both physicians and patients. Furthermore, rising healthcare costs and greater awareness of improved pharmaceutical administration methods have accelerated the global usage of injection pens.

Competitive Landscape

The injection pen market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support. The organizations are focusing on innovating their product line to serve the vast population in diverse regions.

Some of the prominent players operating in the injection pen market include:

Novo Nordisk A/S

Medtronic plc

Becton, Dickinson and Company

Sanofi

Eli Lilly and Company

Merck

AstraZeneca

Hoffmann-La Roche Ltd.

Owen Mumford Ltd

Ypsomed AG

Terumo Medical Corporation

Braun Medical

Sun Pharmaceutical Industries Ltd.

Latest Developments

In April 2021, Roche Diabetes Care France and BioCorp will debut the Mallya smart insulin pen device in France.

In March 2022, Novo Nordisk announced its first smart insulin pens. The NovoPen Echo Plus and NovoPen 6 are insulin self-injection pens that gather data, such as how much and when insulin is administered, and then upload it to an app via a near-field communication (NFC) link for healthcare professionals and patients to review.

1 INTRODUCTION

1.1 MARKET DEFINITION
1.2 MARKET SEGMENTATION
1.3 RESEARCH TIMELINES
1.4 ASSUMPTIONS
1.5 LIMITATIONS

2 RESEARCH METHODOLOGY

2.1 DATA MINING
2.2 SECONDARY RESEARCH
2.3 PRIMARY RESEARCH
2.4 SUBJECT MATTER EXPERT ADVICE
2.5 QUALITY CHECK
2.6 FINAL REVIEW
2.7 DATA TRIANGULATION
2.8 BOTTOM-UP APPROACH
2.9 TOP-DOWN APPROACH
2.10 RESEARCH FLOW
2.11 DATA SOURCES

3 EXECUTIVE SUMMARY

3.1 GLOBAL INJECTION PEN MARKET OVERVIEW
3.2 GLOBAL INJECTION PEN ESTIMATES AND FORECAST (USD MILLION), 2021-2030
3.3 GLOBAL INJECTION PEN ECOLOGY MAPPING
3.4 COMPETITIVE ANALYSIS: FUNNEL DIAGRAM
3.5 GLOBAL INJECTION PEN ABSOLUTE MARKET OPPORTUNITY
3.6 GLOBAL INJECTION PEN MARKET ATTRACTIVENESS ANALYSIS, BY REGION
3.7 GLOBAL INJECTION PEN MARKET ATTRACTIVENESS ANALYSIS, BY PRODUCT
3.8 GLOBAL INJECTION PEN MARKET ATTRACTIVENESS ANALYSIS, BY APPLICATION
3.9 GLOBAL INJECTION PEN MARKET ATTRACTIVENESS ANALYSIS, BY DOSAGE
3.10 GLOBAL INJECTION PEN MARKET ATTRACTIVENESS ANALYSIS, BY END-USERS
3.11 GLOBAL INJECTION PEN MARKET ATTRACTIVENESS ANALYSIS, BY PEN ACCESSORIES
3.12 GLOBAL INJECTION PEN MARKET GEOGRAPHICAL ANALYSIS (CAGR %)
3.13 GLOBAL INJECTION PEN MARKET, BY PRODUCT (USD MILLION)
3.14 GLOBAL INJECTION PEN MARKET, BY APPLICATION (USD MILLION)
3.15 GLOBAL INJECTION PEN MARKET, BY DOSAGE (USD MILLION)
3.16 GLOBAL INJECTION PEN MARKET, BY END-USERS (USD MILLION)
3.17 GLOBAL INJECTION PEN MARKET, BY PEN ACCESSORIES (USD MILLION)
3.18 GLOBAL INJECTION PEN MARKET, BY GEOGRAPHY (USD MILLION)
3.19 FUTURE MARKET OPPORTUNITIES

4 MARKET OUTLOOK

4.1 GLOBAL INJECTION PEN MARKET EVOLUTION
4.2 INJECTION PEN MARKET OUTLOOK
4.3 MARKET DRIVERS
- 4.3.1 RISING PREVALENCE OF CHRONIC DISEASES
- 4.3.2 INCREASING GERIATRIC POPULATION
4.4 MARKET RESTRAINTS
- 4.4.1 HIGH COST OF INJECTION PENS
- 4.4.2 NEEDLE-STICK INJURIES AND MISUSE
4.5 MARKET TRENDS
- 4.5.1 TECHNOLOGICAL ADVANCEMENTS
- 4.5.2 RISING POPULARITY OF SELF-ADMINISTRATION OF DRUGS
4.6 MARKET OPPORTUNITY
- 4.6.1 CAPITALIZING ON BIODEGRADABLE PEN MATERIALS
- 4.6.2 EXPANSION INTO EMERGING MARKET
4.7 PORTER'S FIVE FORCES ANALYSIS
- 4.7.1 THREAT OF NEW ENTRANTS
- 4.7.2 THREAT OF SUBSTITUTES
- 4.7.3 BARGAINING POWER OF SUPPLIERS
- 4.7.4 BARGAINING POWER OF BUYERS
- 4.7.5 COMPETITIVE RIVALRY
4.8 MACROECONOMIC ANALYSIS
4.9 VALUE CHAIN ANALYSIS
4.10 PRICING ANALYSIS
4.11 ANALYSIS ON ACCESSORY CASES FOR INJECTION PENS
4.12 GLOBAL OBESITY OUTLOOK
4.13 GLP-1RA ADOPTION IN INJECTION PENS AND ITS IMPACT ON DIABETICS AND OBESITY
4.14 GROWTH HARMONE DEFICIENCY AND ITS MARKET TRENDS
4.15 LIST OF TOP INJECTION PENS

5 MARKET, BY PRODUCT

5.1 OVERVIEW
5.2 GLOBAL INJECTION PEN MARKET: BASIS POINT SHARE (BPS) ANALYSIS, BY PRODUCT
5.3 DISPOSABLE
5.4 REUSABLE

6 MARKET, BY DOSAGE

6.1 OVERVIEW
6.2 GLOBAL INJECTION PEN MARKET: BASIS POINT SHARE (BPS) ANALYSIS, BY DOSAGE
6.3 FIXED
6.4 VARIABLE

7 MARKET, BY APPLICATION

7.1 OVERVIEW
7.2 GLOBAL INJECTION PEN MARKET: BASIS POINT SHARE (BPS) ANALYSIS, BY APPLICATION
7.3 DIABETES
7.4 ANAPHYLAXIS
7.5 OSTEOPOROSIS
7.6 GROWTH HORMONE DEFICIENCY
7.7 ARTHRITIS
7.8 OTHERS

8 MARKET, BY END USERS

8.1 OVERVIEW
8.2 GLOBAL INJECTION PEN MARKET: BASIS POINT SHARE (BPS) ANALYSIS, BY END USERS
8.3 HOSPITALS & DIAGNOSTIC CENTERS
8.4 HOMECARE

9 MARKET, BY PEN ACCESSORIES

9.1 OVERVIEW
9.2 PEN NEEDLE TIPS
9.3 NEEDLE COVERS OR SHIELDS
9.4 CARRY CASES
9.5 PEN GRIPS OR HOLDERS

10 MARKET, BY GEOGRAPHY

10.1 OVERVIEW
10.2 NORTH AMERICA
- 10.2.1 NORTH AMERICA MARKET SNAPSHOT
- 10.2.2 U.S.
- 10.2.3 CANADA
- 10.2.4 MEXICO
10.3 EUROPE
- 10.3.1 EUROPE MARKET SNAPSHOT
- 10.3.2 GERMANY
- 10.3.3 U.K.
- 10.3.4 FRANCE
- 10.3.5 ITALY
- 10.3.6 SPAIN
- 10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
- 10.4.1 ASIA PACIFIC MARKET SNAPSHOT
- 10.4.2 CHINA
- 10.4.3 JAPAN
- 10.4.4 INDIA
- 10.4.5 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
- 10.5.1 LATIN AMERICA MARKET SNAPSHOT
- 10.5.2 BRAZIL
- 10.5.3 ARGENTINA
- 10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST AND AFRICA
- 10.6.1 MIDDLE EAST AND AFRICA MARKET SNAPSHOT
- 10.6.2 UAE
- 10.6.3 SAUDI ARABIA
- 10.6.4 SOUTH AFRICA
- 10.6.5 REST OF MIDDLE EAST AND AFRICA

11 COMPETITIVE LANDSCAPE

11.1 OVERVIEW
11.2 KEY DEVELOPMENT
11.3 COMPANY MARKET RANKING ANALYSIS
11.4 COMPANY REGIONAL FOOTPRINT
11.5 ACE MATRIX
- 11.5.1 ACTIVE
- 11.5.2 CUTTING EDGE
- 11.5.3 EMERGING
- 11.5.4 INNOVATORS

12 GLOBAL INJECTION PEN MARKET COMPANY PROFILES

12.1 ELI LILLY AND COMPANY
- 12.1.1 COMPANY OVERVIEW
- 12.1.2 COMPANY INSIGHTS
- 12.1.3 PRODUCT BENCHMARKING
- 12.1.4 KEY DEVELOPMENTS
- 12.1.5 WINNING IMPERATIVES
- 12.1.6 CURRENT FOCUS & STRATEGIES
- 12.1.7 SWOT ANALYSIS
- 12.1.8 THREAT FROM COMPETITION
12.2 SANOFI SA
- 12.2.1 COMPANY OVERVIEW
- 12.2.2 COMPANY INSIGHTS
- 12.2.3 PRODUCT BENCHMARKING
- 12.2.4 KEY DEVELOPMENTS
- 12.2.5 SWOT ANALYSIS
- 12.2.6 WINNING IMPERATIVES
- 12.2.7 CURRENT FOCUS & STRATEGIES
- 12.2.8 THREAT FROM COMPETITION
12.3 NOVO NORDISK A/S
- 12.3.1 COMPANY OVERVIEW
- 12.3.2 COMPANY INSIGHTS
- 12.3.3 PRODUCT BENCHMARKING
- 12.3.4 KEY DEVELOPMENTS
- 12.3.5 WINNING IMPERATIVES
- 12.3.6 CURRENT FOCUS & STRATEGIES
- 12.3.7 SWOT ANALYSIS
- 12.3.8 THREAT FROM COMPETITION
12.4 MERCK KGAA
- 12.4.1 COMPANY OVERVIEW
- 12.4.2 COMPANY INSIGHTS
- 12.4.3 PRODUCT BENCHMARKING
- 12.4.4 KEY DEVELOPMENTS
- 12.4.5 WINNING IMPERATIVES
- 12.4.6 CURRENT FOCUS & STRATEGIES
- 12.4.7 THREAT FROM COMPETITION
12.5 TEVA PHARMACEUTICALS INDUSTRIES LTD.
- 12.5.1 COMPANY OVERVIEW
- 12.5.2 COMPANY INSIGHTS
- 12.5.3 PRODUCT BENCHMARKING
- 12.5.4 KEY DEVELOPMENTS
- 12.5.5 WINNING IMPERATIVES
- 12.5.6 CURRENT FOCUS & STRATEGIES
- 12.5.7 THREAT FROM COMPETITION
12.6 OWEN MUMFORD
- 12.6.1 COMPANY OVERVIEW
- 12.6.2 COMPANY INSIGHTS
- 12.6.3 PRODUCT BENCHMARKING
- 12.6.4 KEY DEVELOPMENTS
- 12.6.5 WINNING IMPERATIVES
- 12.6.6 CURRENT FOCUS & STRATEGIES
- 12.6.7 THREAT FROM COMPETITION
12.7 HASELMEIER GMBH
- 12.7.1 COMPANY OVERVIEW
- 12.7.2 COMPANY INSIGHTS
- 12.7.3 PRODUCT BENCHMARKING
- 12.7.4 KEY DEVELOPMENTS
- 12.7.5 WINNING IMPERATIVES
- 12.7.6 CURRENT FOCUS & STRATEGIES
- 12.7.7 THREAT FROM COMPETITION
12.8 GERRESHEIMER AG
- 12.8.1 COMPANY OVERVIEW
- 12.8.2 COMPANY INSIGHTS
- 12.8.3 PRODUCT BENCHMARKING
- 12.8.4 WINNING IMPERATIVES
- 12.8.5 CURRENT FOCUS & STRATEGIES
- 12.8.6 THREAT FROM COMPETITION
12.9 BIOCON LIMITED
- 12.9.1 COMPANY OVERVIEW
- 12.9.2 COMPANY INSIGHTS
- 12.9.3 PRODUCT BENCHMARKING
- 12.9.4 WINNING IMPERATIVES
- 12.9.5 CURRENT FOCUS & STRATEGIES
- 12.9.6 THREAT FROM COMPETITION
12.10 BD (BECKTON DISCKINSON CO)
- 12.10.1 COMPANY OVERVIEW
- 12.10.2 COMPANY INSIGHTS
- 12.10.3 PRODUCT BENCHMARKING
- 12.10.4 KEY DEVELOPMENTS
- 12.10.5 WINNING IMPERATIVES
- 12.10.6 CURRENT FOCUS & STRATEGIES
- 12.10.7 THREAT FROM COMPETITION
12.11 ASTRAZENECA
- 12.11.1 COMPANY OVERVIEW
- 12.11.2 COMPANY INSIGHTS
- 12.11.3 PRODUCT BENCHMARKING
- 12.11.4 WINNING IMPERATIVES
- 12.11.5 CURRENT FOCUS & STRATEGIES
- 12.11.6 THREAT FROM COMPETITION
12.12 SHL MEDICAL
- 12.12.1 COMPANY OVERVIEW
- 12.12.2 COMPANY INSIGHTS
- 12.12.3 PRODUCT BENCHMARKING
- 12.12.4 KEY DEVELOPMENTS
- 12.12.5 WINNING IMPERATIVES
- 12.12.6 CURRENT FOCUS & STRATEGIES
- 12.12.7 THREAT FROM COMPETITION
12.13 NOVARTIS AG
- 12.13.1 COMPANY OVERVIEW
- 12.13.2 COMPANY INSIGHTS
- 12.13.3 PRODUCT BENCHMARKING
- 12.13.4 KEY DEVELOPMENTS
- 12.13.5 WINNING IMPERATIVES
- 12.13.6 CURRENT FOCUS & STRATEGIES
- 12.13.7 THREAT FROM COMPETITION
12.14 SOLTEAM INCORPORATION CO., LTD.
- 12.14.1 COMPANY OVERVIEW
- 12.14.2 COMPANY INSIGHTS
- 12.14.3 PRODUCT BENCHMARKING
- 12.14.4 KEY DEVELOPMENTS
- 12.14.5 WINNING IMPERATIVES
- 12.14.6 CURRENT FOCUS & STRATEGIES
- 12.14.7 THREAT FROM COMPETITION
12.15 YPSOMED AG
- 12.15.1 COMPANY OVERVIEW
- 12.15.2 COMPANY INSIGHTS
- 12.15.3 PRODUCT BENCHMARKING
- 12.15.4 KEY DEVELOPMENTS
- 12.15.5 WINNING IMPERATIVES
- 12.15.6 CURRENT FOCUS & STRATEGIES
- 12.15.7 THREAT FROM COMPETITION
12.16 ROCHE HOLDING AG
- 12.16.1 COMPANY OVERVIEW
- 12.16.2 COMPANY INSIGHTS
- 12.16.3 PRODUCT BENCHMARKING
- 12.16.4 KEY DEVELOPMENTS
- 12.16.5 WINNING IMPERATIVES
- 12.16.6 CURRENT FOCUS & STRATEGIES
- 12.16.7 THREAT FROM COMPETITION
12.17 NORDIC PHARMA
- 12.17.1 COMPANY OVERVIEW
- 12.17.2 COMPANY INSIGHTS
- 12.17.3 PRODUCT BENCHMARKING
- 12.17.4 KEY DEVELOPMENTS
- 12.17.5 WINNING IMPERATIVES
- 12.17.6 CURRENT FOCUS & STRATEGIES
- 12.17.7 THREAT FROM COMPETITION
12.18 PHILLIPS-MEDISIZE CORPORATION (A MOLEX COMPANY)
- 12.18.1 COMPANY OVERVIEW
- 12.18.2 COMPANY INSIGHTS
- 12.18.3 PRODUCT BENCHMARKING
- 12.18.4 KEY DEVELOPMENTS
- 12.18.5 WINNING IMPERATIVES
- 12.18.6 CURRENT FOCUS & STRATEGIES
- 12.18.7 THREAT FROM COMPETITION
12.19 MEDTRONIC
- 12.19.1 COMPANY OVERVIEW
- 12.19.2 COMPANY INSIGHTS
- 12.19.3 PRODUCT BENCHMARKING
- 12.19.4 KEY DEVELOPMENTS
- 12.19.5 WINNING IMPERATIVES
- 12.19.6 CURRENT FOCUS & STRATEGIES
- 12.19.7 THREAT FROM COMPETITION

13 GLOBAL INJECTION PEN ACCESSORIES MARKET COMPANY PROFILES

13.1 DIABETES EXPRESS
- 13.1.1 COMPANY OVERVIEW
- 13.1.2 COMPANY INSIGHTS
- 13.1.3 PRODUCT BENCHMARKING
13.2 DIABETICWAREHOUSE
- 13.2.1 COMPANY OVERVIEW
- 13.2.2 COMPANY INSIGHTS
- 13.2.3 PRODUCT BENCHMARKING
13.3 4ALLFAMILY
- 13.3.1 COMPANY OVERVIEW
- 13.3.2 COMPANY INSIGHTS
- 13.3.3 PRODUCT BENCHMARKING

インジェクションペン市場：製品、用途、エンドユーザー、ペン付属品、用量、地域別、2024年～2031年

Injection Pen Market By Product, Application, End-Users, Pen Accessories, Dosage, & Region for 2024-2031

インジェクションペン市場の評価、2024年～2031年

技術進歩の増加はインジェクションペン市場を牽引するか？

代替ドラッグデリバリーはインジェクションペン市場の妨げになるか？

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場展望

第5章 製品別市場

第6章 用量別市場

第7章 用途別市場

第8章 エンドユーザー別市場

第9章 ペン付属品別市場

第10章 地域別市場

第11章 競合情勢

第12章 世界のインジェクションペン市場、企業プロファイル

第13章 世界のインジェクションペン付属品市場、企業プロファイル